Quoin Pharmaceuticals
Nasdaq QNRX · Ashburn, VA
Works in Dermatology · Genetic & rare
Quoin Pharmaceuticals is a clinical trial sponsor based in Ashburn, VA, listed as Nasdaq QNRX. It has 4 active clinical trials with 74 planned participants, in Dermatology and Genetic & rare.
Trial track record · since 2021
Financials · Nasdaq QNRX
Fundraising
Pipeline · 4 active trials
| Stage | Trial | Status |
|---|---|---|
Questions about Quoin Pharmaceuticals
Quoin Pharmaceuticals is lead sponsor of 4 active clinical trials on ClinicalTrials.gov, with 74 planned participants, in Dermatology, Genetic & rare. Since 2021 it has completed 0 trials and stopped 0 early.
Quoin Pharmaceuticals is based in Ashburn, VA and is listed as Nasdaq QNRX. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Quoin Pharmaceuticals; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-09-28.
Approve Suite is not affiliated with Quoin Pharmaceuticals.
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.